State Street
MAIA icon

State Street’s MAIA Biotechnology MAIA Stock Holding History

State Street’s Portfolio MAIA Stock Details MAIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$291K Buy
201,750
+62,800
+45% +$83.4K ﹤0.01% 3724
2026
Q1 		$195K Buy
138,950
+63,400
+84% +$117K ﹤0.01% 3894
2025
Q4 		$116K Hold
75,550
– – ﹤0.01% 4021
2025
Q3 		$116K Hold
75,550
– – ﹤0.01% 4024
2025
Q2 		$136K Buy
75,550
+22,300
+42% +$39.9K ﹤0.01% 3919
2025
Q1 		$81.5K Hold
53,250
– – ﹤0.01% 4014
2024
Q4 		$105K Buy
53,250
+18,850
+55% +$45.2K ﹤0.01% 3977
2024
Q3 		$96.7K Hold
34,400
– – ﹤0.01% 3983
2024
Q2 		$118K Buy
34,400
+13,100
+62% +$41.3K ﹤0.01% 3961
2024
Q1 		$46.9K Hold
21,300
– – ﹤0.01% 4173
2023
Q4 		$24.9K Buy
+21,300
New +$34.4K ﹤0.01% 4322

Other funds holding MAIA

SCM
Solas Capital Management Darien, Connecticut $187M AUM 12.91% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
CWM
Centric Wealth Management Chicago, Illinois $643M AUM 21% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street's MAIA Position: Q2 2026 in Review

State Street increased its MAIA Biotechnology (MAIA) stake by 45% in Q2 2026, buying an estimated $83.4K and bringing the position to 201,750 shares worth $291K. The position accounts for ﹤0.01% of the portfolio, ranked #3724.

State Street first reported a position in MAIA in Q4 2023 and has held it in 11 quarters since. 36 funds tracked by Wall St. Rank hold MAIA as of Q2 2026.

  • State Street held 201,750 shares of MAIA Biotechnology worth $291K as of Q2 2026.
  • State Street bought 62,800 MAIA Biotechnology shares in Q2 2026, an estimated $83.4K.
  • MAIA Biotechnology made up ﹤0.01% of State Street's portfolio in Q2 2026, its #3724 holding.
  • State Street first reported a position in MAIA Biotechnology in Q4 2023 and has held it in 11 quarters since.
  • 36 funds tracked by Wall St. Rank held MAIA Biotechnology as of Q2 2026.

Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.